General
Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates
A study has found treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive care.
Key points:
- The study involved 800 severely ill COVID-19 patients
- The UK Government said the drugs will be used to treat critically ill COVID-19 patients
- Results showed that on average, patients treated with Actemra or Kevzara recovered more swiftly
The findings, which have not yet been peer-reviewed, showed that the immunosuppressive drugs — Actemra, also known as tocilizumab, and Kevzara, also known as sarilumab — reduced death rates by 8.5 percentage points among patients hospitalised and severely ill with the pandemic…
Continue Reading
-
General19 hours agoVictorian school teacher charged with soliciting child abuse material
-
General11 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News15 hours agoPalestine protesters forced into last-minute reroute
-
Business15 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?